Investment Insights for 2025: Moderna and Beyond
As the world’s top investment manager, I am always on the lookout for promising opportunities in the market. In my recent Outlook for 2025, I highlighted 10 picks that I believe have great potential. However, there are also some Honorable Mention stocks that deserve attention, despite facing challenges in the past. Moderna (NASDAQ:) is one such stock that stands out.
Breaking Down the Headlines
- Moderna shares surged by nearly 14% following the first bird-flu death in the U.S.
- The biotech company is actively working on developing a vaccine for H5N1.
- Despite recent gains, Moderna shares have seen a decline of over 55% in the past year.
Insights on Moderna and the ETF
In the Outlook 2025, there is mention of the ETF or a member of the Economic Modern Family, specifically Big Brother Biotechnology (IBB). The expectation is that if IBB holds the 80-month moving average, we could see an uptrend driven by advancements in immunology and treatment solutions.
Analyzing Moderna’s Performance
Looking at the daily chart of Moderna, we can see a significant downtrend from June 1024 to January 7th. However, recent developments have shown a positive change with Moderna clearing the 50-DMA. This could signal a shift from a bearish trend to a path of recovery.
A Summary of ETF Performance
- S&P 500 (SPY): Currently below the 50-DMA
- Russell 2000 (IWM): Next support at 220, potential trouble below
- Dow (DIA): Pivotal support at 422
- Nasdaq (QQQ): Testing the 50-DMA, a critical level to watch
- Regional banks (KRE): Resistance at 65, support at 58
- Semiconductors (SMH): Key level at 260
- Transportation (IYT): Support at 68, resistance at 70
- Biotechnology (IBB): Pivotal level at 135
- Retail (XRT): Critical support at 80.50
- iShares iBoxx Hi Yd Cor Bond ETF (HYG): Below the 200-week MA
Analyzing the Impact
For those new to finance, understanding these insights can provide valuable information about market trends and potential investment opportunities. By keeping an eye on stocks like Moderna and monitoring the performance of key ETFs, investors can make informed decisions that align with their financial goals and aspirations. Stay informed, stay engaged, and reap the benefits of a well-informed investment strategy.